Professor of Medicine
David Vesely MD, PhD recently retired as Chief of Endocrinology, Diabetes and Metabolism at the James A. Haley Veterans' Medical Center. David served as Director of the Cardiac Hormone Center, University of South Florida College of Medicine (U.S.FCM). He serves as a member of the Scientific Advisory Boards at TransGenex and Nanobiotech, Inc. Dr. Vesely was a Full Professor at U.S.FCM, Departments of Medicine and of Physiology and Biophysics. He established the clinical potential of renopeptins and carried out the set of clinical trials in the U.S.